STRATA Skin Sciences Files 8-K
Ticker: SSKN · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1051514
| Field | Detail |
|---|---|
| Company | Strata Skin Sciences, Inc. (SSKN) |
| Form Type | 8-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $2.204 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
STRATA Skin Sciences filed an 8-K on Sept 4, 2025, for Reg FD and financials.
AI Summary
STRATA Skin Sciences, Inc. filed an 8-K on September 4, 2025, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as MELA SCIENCES, INC. and ELECTRO OPTICAL SCIENCES INC, is headquartered in Horsham, PA.
Why It Matters
This filing indicates routine corporate reporting, including financial updates and regulatory disclosures, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for corporate disclosures and does not appear to contain significant new material events.
Key Players & Entities
- STRATA Skin Sciences, Inc. (company) — Registrant
- MELA SCIENCES, INC. (company) — Former Company Name
- ELECTRO OPTICAL SCIENCES INC (company) — Former Company Name
- September 4, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report for STRATA Skin Sciences, Inc., covering Regulation FD Disclosure and Financial Statements and Exhibits.
When was this 8-K report filed?
The report was filed on September 4, 2025.
What are the former names of STRATA Skin Sciences, Inc.?
The company was formerly known as MELA SCIENCES, INC. and ELECTRO OPTICAL SCIENCES INC.
Where is STRATA Skin Sciences, Inc. headquartered?
The company's principal executive offices are located at 5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania 19044.
What is the Standard Industrial Classification (SIC) code for STRATA Skin Sciences, Inc.?
The SIC code for STRATA Skin Sciences, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 563 words · 2 min read · ~2 pages · Grade level 9.4 · Accepted 2025-09-04 16:31:12
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ
- $2.204 — stock at a per share purchase price of $2.204. Ladenburg Thalmann & Co. Inc. acted as
Filing Documents
- ef20055131_8k.htm (8-K) — 28KB
- ef20055131_ex99-1.htm (EX-99.1) — 9KB
- image0.jpg (GRAPHIC) — 209KB
- 0001140361-25-034000.txt ( ) — 687KB
- sskn-20250904.xsd (EX-101.SCH) — 4KB
- sskn-20250904_lab.xml (EX-101.LAB) — 21KB
- sskn-20250904_pre.xml (EX-101.PRE) — 16KB
- ef20055131_8k_htm.xml (XML) — 4KB
01
Item 7.01. Regulation FD Disclosure. On September 4, 2025, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing the closing of its previously announced registered direct offering for the issuance and sale of 1,097,547 shares of the Company's common stock at a per share purchase price of $2.204. Ladenburg Thalmann & Co. Inc. acted as exclusive placement agent for the offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following presentation is furnished as an exhibit to this Current Report on Form 8-K and shall not be deemed to be "filed": Exhibit No. Exhibit Description 99.1 Press Release dated September 4, 2025, Issued by Strata Skin Sciences, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: September 4, 2025 By: /s/ John Gillings John Gillings Chief Accounting Officer